Story · Medicine & Biotech

ConCourt to rule on generic cancer drug patent battle

1 outlet · first reported by Medical Brief 11h ago

Coverage, in order

  1. 11h ago
    Medical Brief ZA indie
    ConCourt to rule on generic cancer drug patent battle

    Japan­ese pharma giant Astel­las and the Uni­versity of Cali­for­nia (UC) are heading to the Con­sti­tu­tional Court to try to block local pharma group Euro­lab and Dis-Chem from mak­ing and dis­trib­ut­ing Enzutix , a gen­eric of the expensive pro­state can­cer drug Xtandi , reports the Sunday…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.